Atlas Trials

Regulation of Arginine-vasopressin (AVP)

Clinical trial NCT02626832 · COMPLETED

Trial details

NCT number
NCT02626832
Sponsor
Yale University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaDepression
Start date
2010-02-01
Primary completion
2013-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.